Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ghrayeb

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|June 1, 1988
Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblastsP B Sehgal, D C Helfgott, U Santhanam, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitisH Körner, A L Goodsall, F A Lemckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1987
Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigenD R Shaw, M B Khazaeli, L K Sun, et al.
Pharmaceutical Research|June 1, 1990
Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.
European Journal of Immunology|May 1, 1996
Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retinaA D Dick, P G McMenamin, H Körner, et al.
Journal of Biological Response Modifiers|April 1, 1988
Human lymphocyte and monocyte lysis of tumor cells mediated by a mouse/human IgG1 chimeric monoclonal antibodyD R Shaw, G Harrison, L K Sun, et al.
Cytokine|November 1, 1994
TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cellsD M Butler, B Scallon, A Meager, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Mouse/human chimeric monoclonal antibody in man: kinetics and immune responseA F LoBuglio, R H Wheeler, J Trang, et al.
The Journal of Biological Chemistry|June 5, 1988
Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytesL T May, J Ghrayeb, U Santhanam, et al.
Molecular Immunology|November 1, 1995
The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regionsD M Knight, C Wagner, R Jordan, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|June 1, 1988
Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblastsP B Sehgal, D C Helfgott, U Santhanam, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitisH Körner, A L Goodsall, F A Lemckert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1987
Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigenD R Shaw, M B Khazaeli, L K Sun, et al.
Pharmaceutical Research|June 1, 1990
Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patientsJ M Trang, A F LoBuglio, R H Wheeler, et al.
European Journal of Immunology|May 1, 1996
Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retinaA D Dick, P G McMenamin, H Körner, et al.
Journal of Biological Response Modifiers|April 1, 1988
Human lymphocyte and monocyte lysis of tumor cells mediated by a mouse/human IgG1 chimeric monoclonal antibodyD R Shaw, G Harrison, L K Sun, et al.
Cytokine|November 1, 1994
TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cellsD M Butler, B Scallon, A Meager, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Mouse/human chimeric monoclonal antibody in man: kinetics and immune responseA F LoBuglio, R H Wheeler, J Trang, et al.
The Journal of Biological Chemistry|June 5, 1988
Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytesL T May, J Ghrayeb, U Santhanam, et al.
Molecular Immunology|November 1, 1995
The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regionsD M Knight, C Wagner, R Jordan, et al.
Pageof 6